Author:
Lou Weiyang,Liu Jingxing,Ding Bisha,Chen Danni,Xu Liang,Ding Jun,Jiang Donghai,Zhou Lin,Zheng Shusen,Fan Weimin
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference52 articles.
1. Chen RG, Cheng QY, Owusu-Ansah KG, Chen J, Song GY, Xie HY, Zhou L, Xu X, Jiang DH, Zhengi SS. Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma. Am J Cancer Res. 2018;8:1297–306.
2. Montagner A, Le Cam L, Guillou H. beta-catenin oncogenic activation rewires fatty acid catabolism to fuel hepatocellular carcinoma. Gut. 2018. https://doi.org/10.1136/gutjnl-2018-316557 .
3. An P, Xu J, Yu Y, Winkler CA. Host and viral genetic variation in HBV-related hepatocellular carcinoma. Front Genet. 2018;9:261.
4. Soriano V, Young B, Reau N. Report from the international conference on viral hepatitis-2017. AIDS Rev. 2018;20:58–70.
5. Lou W, Liu J, Gao Y, Zhong G, Ding B, Xu L, Fan W. MicroRNA regulation of liver cancer stem cells. Am J Cancer Res. 2018;8:1126–41.